UPMC: UPMC Launches Novasenta to Develop Targeted Immunotherapy Drugs for Cancer
As part of its commitment to investing in translational science that significantly improves the lives of patients, UPMC has launched Novasenta, a drug discovery and development company seeking novel and effective treatments for!-->…